Maximize Your Clinical Site’s Potential at Vit-Buckle Society 2026

As a proud Next-Gen Sponsor of VBS 2026, RetinAI is committed to advancing the future of retinal clinical research through data-driven innovation. Meet with our team in Las Vegas to see how AI-powered workflows and big data transform your clinical research and turn Candidate Identification into your site’s strategic asset.

In retinal clinical trials, the primary driver of operational inefficiency is often invisible until the screening visit. Recent data indicates that 44.5% of all screen failures are attributed specifically to imaging inclusion criteria¹. 

Meet with RetinAI at Vit-Buckle society to see how AI-driven Candidate Identification mitigates this risk. By qualifying patients against complex imaging protocols prior to the screening visit, we help sites transform a high-cost manual burden into a high-yield strategic asset.

Schedule a private 1:1 consultation to review your site’s recruitment workflow.

Why connect with RetinAI at VBS?

• Optimize Site ROI: Reduce the "hidden costs" of screen-fails by identifying eligible candidates timely and with precision
• Bridge the "Last Mile" to Screening: Leverage Customizable Remote Coordinator Support to transition seamlessly from AI-generated patient lists to confirmed screening appointments.
• Enhance the Patient Experience: Minimize unnecessary testing and travel for patients who don't meet criteria, ensuring a smoother, more empathetic trial journey.
• Scale Without Overhead: Use advanced AI to scan your existing imaging databases, surfacing high-potential candidates in seconds rather than weeks of manual review.
• Data-Driven Precision: Move beyond qualitative assessments with AI-driven biomarkers that match your specific protocol requirements.

Meet the Team

• Natasa Jovic, VP Marketing Strategy & Research Partnerships 
• Lisa Williams, Sr. Director Commercial Operations